GlassScriptPhysician profile
Chad Brecher
NPI 1700806478
$1,366.85
in general payments reported to CMS, 2019-2025
13 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $959 · 2020: $22.16 · 2023: $18.65 · 2024: $144 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $666.56 | 2019-2025 | Angio-Seal, Glidesheath Slender, Tr Band |
| Sirtex Medical INC | $266.29 | 2019-2024 | Sir-Spheres Microspheres |
| Galvanize Therapeutics, INC | $133.83 | 2025 | Aliya System |
| Bard Peripheral Vascular, INC. | $56.21 | 2019-2020 | |
| Eisai INC. | $55.01 | 2019-2024 | |
| Medtronic, INC. | $49.66 | 2025 | Kyphon Express II Kyphopak Tray |
| Ipsen Biopharmaceuticals, INC | $34.75 | 2019 | |
| Foundation Medicine, INC. | $23.85 | 2019 | |
| Biocompatibles, INC. | $22.71 | 2019 | |
| Amgen INC. | $19.11 | 2019 | |
| Daiichi Sankyo INC. | $15.52 | 2025 | Enhertu |
| Celgene Corporation | $11.93 | 2019 | |
| Aurobindo Pharma USA, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Brecher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.